Brought to you by 
LabCorp in discussions to acquire CRO PPD for over $8bn
Feb 2017
Executive Summary
According to industry sources Laboratory Corp. of America Holdings (LabCorp) is in discussions to acquire contract research firm Pharmaceutical Product Development Inc. (PPD) for over $8bn including debt. (LabCorp is one of the parties bidding in an auction for PE-owned PPD.)
Deal Industry
- Biotechnology
- Contract Research, Toxicology Testing-CRO
- Pharmaceuticals
- Services
Deal Status
- Preliminary
Deal Type
-
Acquisition
- Full Acquisition
- Acquisition of Private Biotech
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp in discussions to acquire CRO PPD for over $8bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice